| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,220 |
2,026 |
$140K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,938 |
1,745 |
$84K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,146 |
1,111 |
$58K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
965 |
938 |
$44K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
472 |
459 |
$33K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
173 |
167 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
170 |
166 |
$8K |
| 87634 |
|
90 |
87 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
25 |
25 |
$1K |
| 99215 |
Prolong outpt/office vis |
18 |
17 |
$1K |
| 81025 |
|
179 |
179 |
$869.02 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13 |
12 |
$540.01 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
21 |
21 |
$441.25 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
44 |
41 |
$417.77 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
20 |
14 |
$292.19 |